MATRIX METALLOPROTEINASES IN CHILDREN WITH A COMBINED BONE INJURY

There were comprehensively examined 55 children, including 35 children with combined bone injury (average age of 12.6 ± 2.3 years), reference group consisted of 20 apparently healthy children (average age of 11.8 ± 2.7 years) without pathology of the motor system. on the 1-3rd and 30th day after the combined bone injury, changes in the content of matrix metalloproteinases (MMP) and cytokines - transforming growth factor-beta (TGF-β), monocytic chemotactic factor (MCP-1) and macrophage inflammatory protein (MIP-1β) were followed in the dynamics by serum immunoassay determination. It was established that after combined bone injury at the stage of post-traumatic formation of the regenerate by 30th days the serum concentrations of gelatinases (MMP-2, MMP-9) and collagenases (MMP-8) significantly increased, the levels of stromelysins (MMP-3) did not change, and the content of TIMP-1 decreased. Early detection of changes in the blood content of bone biomarkers during the recovery process after a combined trauma in children allows the timely implementing the correction of disturbances and the choice of the optimal individual treatment tactics for a particular patient, taking into account the features of his bone metabolism.

Wang T, Zhang X, Bikle DD. Osteogenic Differentiation of Periosteal Cells During Fracture Healing. J Cell Physiol. 2017; 232(5): 913-21. doi: 10.1002/jcp.25641.

Kostenuik P, Mirza FM. Fracture healing physiology and the quest for therapies for delayed healing and nonunion. J Orthop Res. 2017; 35(2): 213-23. doi: 10.1002/jor.23460.

Hussein AI, Mancini C, Lybrand KE, Cooke ME, Matheny HE, Hogue BL et al. Serum proteomic assessment of the progression of fracture healing. J Orthop Res. 2018; 36(4): 1153-63. doi: 10.1002/jor.23754.

Smirnov I.E., Roshal L.M., Kucherenko A.G., Karaseva O.V., Ponina I.V. Changes in the blood serum content of bone biomarkers and cytokines in children with combined trauma. Rossiyskiy pediatricheskiy zhurnal. 2017; 20(6): 371-8. doi: 10.18821/1560-9561-2017-20-6-371-8. (In Russian)

Wigner NA, Kulkarni N, Yakavonis M, Young M, Tinsley B, Meeks B et al. Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing. Injury. 2012; 43(3): 274-8. doi: 10.1016/j.injury.2011.05.038.

Galyatina T.A., Ustyantseva I.M., Chochlova O.I. Features of bone metabolism in children with extremity fractures. Byulleten sibirskoy meditsiny. 2013; 12(6): 17-24. (in Russian)

Vilaca T, Gossiel F, Eastell R. Bone Turnover Markers: Use in Fracture Prediction. J Clin Densitom. 2017; 20(3): 346-52. doi: 10.1016/j.jocd.2017.06.020.

Oh T, Naka T. Comparison of bone metabolism based on the different ages and competition levels of junior and high school female rhythmic gymnasts. J Exerc Nutrition Biochem. 2017; 21(2): 9-15.

Vervloet MG, Brandenburg VM., Bover J, Brandenburg V, Covic A, Cozzolino M et al. Circulating markers of bone turnover. J Nephrol. 2017. doi: 10.1007/s40620-017-0408-8.

Bemben DA, Sherk VD, Ertl WJJ, Bemben MG. Acute bone changes after lower limb amputation resulting from traumatic injury. Osteoporos Int. 2017; 28(7): 2177-86.

Krokhina K.N., Smirnov I.E., Belyaeva I.A. Features of bone formation in newborns. Rossiyskiy pediatricheskiy zhurnal.2010; 5: 36-41. (In Russian)

Krokhina K.N., Smirnov I.E., Kucherenko A.G., Belyaeva I.A. Dynamics of bone formation markers in newborns in norm and at a pathology. Voprosy diagnostiki v pediatrii. 2011; 3(4): 28-32. (In Russian)

Sucur A, Jajic Z, Artukovic M, Matijasevic MI, Anic B, Flegar D et al. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells. Arthritis Res Ther. 2017; 19(1): 142. doi: 10.1186/s13075-017-1337-6.

Liu C, Cui X, Ackermann TM, Flamini V, Chen W, Castillo AB. Osteoblast-derived paracrine factors regulate angiogenesis in response to mechanical stimulation. Integr Biol (Camb). 2016; 8(7): 785-94.

Franceschi RT, Ge C. Control of the Osteoblast Lineage by Mitogen-Activated Protein Kinase Signaling. Curr Mol Biol Rep. 2017; 3(2): 122-32.

Yang SY, Strong N, Gong X, Heggeness MH. Differentiation of nerve-derived adult pluripotent stem cells into osteoblastic and endothelial cells. Spine J. 2017; 17(2): 277-81.

Movilla N, Borau C, Valero C, García-Aznar JM. Degradation of extracellular matrix regulates osteoblast migration: A microfluidic-based study. Bone. 2017; 107(1): 10-7.

Markelova E.V., Zdor V.V., Romanchuk A.L., Birko O.N. Matrix metalloproteinases: relationship with cytokines system, diagnostic and prognostic potential. Immunopathology, allergology, infectology. 2016; 2: 11-22.doi: 10.14427/jipai.2016.2.11. (In Russian)

Varghese S. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions. Front Biosci. 2006; 11: 2949-66.

Paiva KBS, Granjeiro JM. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair. Prog Mol Biol Transl Sci. 2017; 148: 203-303. doi: 10.1016/bs.pmbts.2017.05.001.

Malemud CJ. Matrix Metalloproteinases and Synovial Joint Pathology. Prog Mol Biol Transl Sci. 2017; 148: 305-25. doi: 10.1016/bs.pmbts.2017.03.003.

Panwar P, Butler GS, Jamroz A, Azizi P, Overall CM, Brömme D. Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. Matrix Biol. 2017. pii: S0945-053X(17)30130-0. doi: 10.1016/j.matbio.2017.06.004.

Haeusler G, Walter I, Helmreich M, Egerbacher M. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcif Tissue Int. 2005; 76(5): 326-35. doi:10.1007/s00223-004-0161-6

Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res. 2000; 15(12): 2431-42. doi:10.1359/jbmr.2000.15.12.2431

Liao HT, Chen CT. Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells. World J Stem Cells. 2014; 6(3): 288-95.

Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009; 15(7): 757-65.

Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S et al. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood. 2002; 100(6): 2195-202.

Mitchell CB, O’Neill GM. Cooperative cell invasion: matrix metalloproteinase-mediated incorporation between cells. Mol Biol Cell. 2016; 27(21): 3284-92.

Wang X, Yu YY, Lieu S, Yang F, Lang J, Lu C et al. MMP9 regulates the cellular response to inflammation after skeletal injury. Bone. 2013; 52(1): 111-9. doi: 10.1016/j.bone.2012.09.018.

Crane JL, Xian L, Cao X. Role of TGF-β Signaling in Coupling Bone Remodeling. Methods Mol Biol. 2016; 1344: 287-300. doi: 10.1007/978-1-4939-2966-5_18.

Limmer A, Wirtz DC. Osteoimmunology: Influence of the Immune System on Bone Regeneration and Consumption. Z Orthop Unfall. 2017; 155(3): 273-80.

Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling. J Clin Invest. 2014; 124(2): 466-72.

Weiss S, Baumgart R, Jochum M, Strasburger CJ, Bidlingmaier M. Systemic regulation of distraction osteogenesis: a cascade of biochemical factors. J Bone Miner Res. 2002; 17(7): 1280-9. doi: 10.1359/jbmr.2002.17.7.1280

Weiss S, Zimmermann G, Baumgart R, Kasten P, Bidlingmaier M, Henle P. Systemic regulation of angiogenesis and matrix degradation in bone regeneration--distraction osteogenesis compared to rigid fracture healing. Bone. 2005; 37(6): 781-90. doi: 10.1016/j.bone.2005.06.014

Hvid I, Horn J, Huhnstock S, Steen H. The biology of bone lengthening. J Child Orthop. 2016; 10(6): 487-92. doi: 10.1007/s11832-016-0780-2

Hussein AI, Mancini C, Lybrand KE, Cooke ME, Matheny HE, Hogue BL et al. Serum proteomic assessment of the progression of fracture healing. J Orthop Res. 2018; 36(4): 1153-63. doi: 10.1002/jor.23754.

Henle P, Zimmermann G, Weiss S. Matrix metalloproteinases and failed fracture healing. Bone. 2005; 37(6): 791-8. doi: 10.1016/j.bone.2005.06.015

Fajardo M, Liu CJ, Ilalov K, Egol KA. Matrix metalloproteinases that associate with and cleave bone morphogenetic protein-2 in vitro are elevated in hypertrophic fracture nonunion tissue. J Orthop Trauma. 2010; 24(9): 557-63. doi: 10.1097/BOT.0b013e3181ed294c.

Smirnova G.I., Rumyantsev R.E. Vitamin D and allergic diseases in children. Rossiyskiy pediatricheskiy zhurnal. 2017; 20 (3): 166-172 (in Russian)

Wang T, Zhang X, Bikle DD. Osteogenic Differentiation of Periosteal Cells During Fracture Healing. J Cell Physiol. 2017; 232(5): 913-21. doi: 10.1002/jcp.25641.

Kostenuik P, Mirza FM. Fracture healing physiology and the quest for therapies for delayed healing and nonunion. J Orthop Res. 2017; 35(2): 213-23. doi: 10.1002/jor.23460.

Bigham-Sadegh A, Oryan A. Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures. Int Wound J. 2015; 12(3): 238-47. doi: 10.1111/iwj.12231.

Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol. 2011; 211(2): 109-21. doi: 10.1530/JOE-11-0048.